Clinical Trial Update: A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010) [Phase 1]

View source ↗

Summary

Phase 1 study MK-5684-010 in male participants with severe renal impairment and end-stage kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Kidney Disease

Drugs mentioned

• MK-5684 (MK-5684)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Kidney Failure, Chronic, End-Stage Kidney Disease | Phase 1 | Status: COMPLETED